|
|
Vaccine Detail
|
Pulmonary BCG immunotherapy for malignant melanoma |
| Vaccine Information |
- Vaccine Name: Pulmonary BCG immunotherapy for malignant melanoma
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007650
- Type: Live, attenuated vaccine
- Status: Research
- Immunization Route: Intramuscular injection (i.m.)
- Description: Used by some investigators for the treatment of early or metastatic malignant melanoma. The use of BCG by scarification or intralesionally can cause local and systemic complications, whereas BCG given orally may cause gastrointestinal symptoms but rarely causes systemic side effects (Bilgi et al., 1979).
|
| Host Response |
|
|
| References |
Bilgi et al., 1979: Bilgi C, Brown NE, McPherson TA, Lentle B. Pulmonary manifestations in patients with malignant melanoma during BCG immunotherapy. A preliminary report. Chest. 1979; 75(6); 685-687. [PubMed: 436519].
|
|
